INTERACTIONS BETWEEN THE FINGER AND KRINGLE-2 DOMAINS OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR-1

被引:13
作者
KANEKO, M [1 ]
SAKATA, Y [1 ]
MATSUDA, M [1 ]
MIMURO, J [1 ]
机构
[1] JICHI MED SCH, INST HEMATOL, DIV HEMOSTASIS & THROMBOSIS RES, MINAMI KAWACHI, TOCHIGI 32904, JAPAN
关键词
D O I
10.1093/oxfordjournals.jbchem.a123744
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have shown that plasminogen activator inhibitor-1 (PAI-1) inhibits the fibrin binding of both the single chain and two chain forms of tissue-type plasminogen activator (tPA) through two different mechanisms. PAI-I inhibits the finger domain-dependent fibrin binding of diisopropylfluorophosphate-inactivated single chain tPA and the kringle-2 domain-dependent fibrin binding of diisopropylfluorophosphate-inactivated two chain tPA. In accordance with the data, preformed complexes of single chain tPA/PAI-1 and of two chain tPA/PAI-1 lost the fibrin binding abilities mediated by the finger and kringle-2 domains, respectively. These effects of PAI-1 appear to be mediated by steric hindrance of the fibrin binding sites after PAI-1 binding to adjacent regions in the functional domains of tPA. We thus propose a model in which a PAI-1 binding site resides in the finger domain of a single chain, and plays a role in the reversible association of single chain tPA and PAI-1. Conformational changes may take place during the conversion of single chain tPA to two chain tPA, resulting in burying of the original PAI-1 binding site and exposure of an alternate PAI-1 binding site on the surface of the kringle-2 domain.
引用
收藏
页码:244 / 248
页数:5
相关论文
共 19 条
[2]  
BLOMBACK B, 1957, ARK KEMI, V10, P415
[3]   THE FIBRINOLYTIC SYSTEM IN MAN [J].
COLLEN, D ;
LIJNEN, HR .
CRC CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY, 1986, 4 (03) :249-301
[4]   PLASMINOGEN ACTIVATORS, TISSUE DEGRADATION, AND CANCER [J].
DANO, K ;
ANDREASEN, PA ;
GRONDAHLHANSEN, J ;
KRISTENSEN, P ;
NIELSEN, LS ;
SKRIVER, L .
ADVANCES IN CANCER RESEARCH, 1985, 44 :139-266
[5]  
DEVRIES C, 1989, J BIOL CHEM, V264, P12604
[6]   KINETIC-ANALYSIS OF THE INTERACTIONS BETWEEN PLASMINOGEN-ACTIVATOR INHIBITOR-1 AND BOTH UROKINASE AND TISSUE PLASMINOGEN-ACTIVATOR [J].
HEKMAN, CM ;
LOSKUTOFF, DJ .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1988, 262 (01) :199-210
[7]   THE PLASMINOGEN-ACTIVATOR INHIBITOR-1 BINDING-SITE IN THE KRINGLE-2 DOMAIN OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR [J].
KANEKO, M ;
MIMURO, J ;
MATSUDA, M ;
SAKATA, Y .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 178 (03) :1160-1166
[8]  
LIJNEN HR, 1991, J BIOL CHEM, V266, P4041
[9]  
LOSKUTOFF DJ, 1989, PROG HEMOST THROMB, V9, P87
[10]   AMINO-ACID-RESIDUES THAT AFFECT INTERACTION OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR WITH PLASMINOGEN-ACTIVATOR INHIBITOR-1 [J].
MADISON, EL ;
GOLDSMITH, EJ ;
GERARD, RD ;
GETHING, MJH ;
SAMBROOK, JF ;
BASSELDUBY, RS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (09) :3530-3533